Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Women'S Health (London, England)|May 5, 2012
Assessment of the use of two new low-dose levonorgestrel-releasing intrauterine systems as contraceptivesLuis Bahamondes, M Valeria BahamondesActa Obstetricia Et Gynecologica Scandinavica|January 23, 2021
Intrauterine device use is safe among nulligravidas and adolescent girlsM Valeria Bahamondes, Luis BahamondesInternational Journal of Women'S Health|February 27, 2014
New and emerging contraceptives: a state-of-the-art reviewLuis Bahamondes, M Valeria BahamondesHuman Reproduction (Oxford, England)|May 10, 2014
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptivesWaleska Modesto, M Valeria Bahamondes, Luis BahamondesExpert Review of Medical Devices|June 25, 2008
Levonorgestrel-releasing intrauterine system: uses and controversiesLuis Bahamondes, M Valeria Bahamondes, Ilza MonteiroHuman Reproduction Update|June 4, 2015
Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methodsLuis Bahamondes, M Valeria Bahamondes, Lee P ShulmanHuman Reproduction (Oxford, England)|June 5, 2015
Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCTM Valeria Bahamondes, Ximena Espejo-Arce, Luis BahamondesBest Practice & Research. Clinical Obstetrics & Gynaecology|February 5, 2020
Long-acting reversible contraceptive (LARCs) methodsLuis Bahamondes, Arlete Fernandes, Ilza Monteiro, et al.Best Practice & Research. Clinical Obstetrics & Gynaecology|March 26, 2025
Subdermal contraceptive implantsLuis Bahamondes, M Valeria Bahamondes, Cassia R T JuliatoContraception|October 25, 2011
Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidasM Valeria Bahamondes, M Margarete Hidalgo, Luis Bahamondes, et al.Pageof 4